[Metadata] Environmental Sustainability of Digital Display Labels in Clinical Trials – Case Study on Long-Acting Antipsychotic Injections

Structured summary of a life cycle assessment (LCA) comparing digital display labels (DDLs) with conventional paper labels for investigational medicinal products (IMPs) across a multi-site clinical trial involving six countries, for two dosage strengths (1000 mg and 700 mg) of a long-acting antipsychotic injection. The dataset covers goal and scope, inventory and method, hotspot and scenario results, and recommendations. Source: Muindi et al., manuscript in preparation for submission to an open access journal.